Lipid Modulation of Ion Channel Function

Abstract

Ion channels are fundamental membrane proteins that mediate selective ion flow across biological membranes and thereby govern excitability, signaling, and homeostasis in virtually all cell types. Although channel function is determined by intrinsic structural features, the surrounding lipid milieu is now recognized as a decisive regulatory layer. Lipids tune ion channel activity through complementary mechanisms: they can bind directly to channel proteins, reshape bilayer physical properties, or act as signaling messengers that couple extracellular cues to channel gating. In addition, the organization of membranes into lipid microdomains such as rafts and caveolae can cluster channels with receptors and scaffolds, enhancing signaling specificity and efficiency. Recent advances in cryo-electron microscopy and molecular simulations have expanded our understanding of these lipid–channel interactions, revealing lipids as active modulators rather than passive structural components. This review provides a comprehensive overview of the principles by which lipids regulate ion channel function and highlights the biological and potential clinical significance of this fundamental interplay.

1. Introduction

The plasma membrane is a dynamic and structurally complex system that extends far beyond the classical description of a passive boundary between intracellular and extracellular environments. Composed of a fluid lipid bilayer enriched in proteins, carbohydrates, and cholesterol, it serves as an active regulatory platform for signaling, adhesion, transport, and energy exchange. The biophysical properties of the membrane—including lipid composition, curvature, lateral pressure, and fluidity—directly shape the behavior of embedded proteins. Among them, ion channels are particularly sensitive to changes in their lipid environment [1].

Ion channels are integral membrane proteins that allow the selective passage of ions in response to electrical, chemical, or mechanical stimuli. Their activity is essential for maintaining membrane potential, regulating osmotic balance, and enabling rapid electrical communication in excitable tissues [2,3]. Classical models of channel gating emphasize intrinsic mechanisms such as voltage sensing, ligand binding, or mechanosensation. However, growing evidence demonstrates that the lipid environment is equally decisive, providing modulatory cues that influence gating, kinetics, and spatial organization [4,5].

Lipid–channel interactions occur at multiple levels. At the molecular scale, specific lipids bind directly to ion channels, stabilizing conformations and tuning their activity. Phosphoinositides, cholesterol, polyunsaturated fatty acids, and sphingolipids exemplify lipid classes that act as functional cofactors, ensuring proper gating and responsiveness [6]. Beyond such direct interactions, the physical properties of the bilayer—its thickness, curvature, and lateral tension—also regulate channel function. These parameters alter hydrophobic matching between lipids and transmembrane segments, thereby reshaping the energetic landscape of channel conformational changes [7]. Mechanosensitive proteins such as Piezo and two-pore domain potassium channels illustrate how bilayer mechanics are translated into electrical signals relevant to touch, vascular tone, and osmoregulation [8,9].

In addition to individual lipid species and bulk bilayer mechanics, the membrane’s organization into microdomains adds further complexity [10]. Lipid rafts—nanoscopic domains enriched in cholesterol and sphingolipids—act as signaling platforms that cluster ion channels with receptors and scaffolding proteins, enhancing the specificity and efficiency of cellular responses [11,12]. Caveolae, flask-shaped invaginations stabilized by caveolins and cavins, contribute to mechanosensing, vesicular trafficking, and compartmentalized signaling [13]. Such spatial organization underscores the importance of membrane heterogeneity in orchestrating channel function within broader signaling networks [14].

The physiological and pathological implications of lipid–channel interactions are extensive [15]. In excitable tissues, subtle alterations in lipid composition can disrupt electrical stability, predispose to arrhythmias, seizures, or neuropathic pain. Beyond the nervous and cardiovascular systems, lipid regulation of ion channels influences immune cell activation, epithelial barrier function, and cancer cell migration [5]. Dysregulated lipid metabolism, as occurs in metabolic syndromes, neurodegenerative disorders, and viral infections, can therefore have profound consequences on ion channel behavior and cellular physiology.

From a translational perspective, targeting lipid–channel interactions holds growing therapeutic potential. Compounds that target lipid-sensitive binding sites on ion channels have been leveraged for analgesic strategies, and interventions aimed at modulating lipid-dependent signaling pathways are being explored for cardiovascular and neurological disorders [16]. By exploiting the lipid sensitivity of ion channels, new pharmacological interventions may achieve greater selectivity and efficacy.

The field has been transformed by recent advances in methodology. High-resolution cryo-electron microscopy (cryo-EM) has revealed lipid-binding pockets and channel conformational landscapes at near-atomic detail [17]. Complementary approaches such as machine learning, molecular dynamics simulations, lipidomics, and membrane reconstitution systems have captured the dynamic interplay between lipids and channels under native-like conditions [18,19]. These tools provide unprecedented insight into mechanistic principles and therapeutic opportunities.

This review aims to provide a comprehensive synthesis of how membrane lipids regulate ion channel activity. We integrate structural, biophysical, and functional evidence to highlight underlying mechanisms, representative examples, and their physiological and pathological relevance. By doing so, we seek to illuminate how the dynamic interplay between membrane lipids and ion channels shapes cellular excitability, signaling, and human health.

Scope and Organization

Given the breadth of both membrane lipid chemistry and the human channel repertoire, this review does not attempt an exhaustive catalog of all lipid classes or all >300 ion channel genes. Instead, it focuses on the principal mechanistic modes by which lipids modulate channels—(i) obligate lipid cofactors and electrostatic modulation, (ii) specific binding to annular or non-annular pockets, (iii) bilayer-mediated effects (thickness, curvature, lateral stress), and (iv) nanoscale membrane organization (rafts/caveolae)—and highlights representative channel families where mechanistic evidence is currently strongest, often supported by primary functional studies and structural snapshots.

2. Cell Membrane Structure and Physicochemical Properties

The plasma membrane is a selectively permeable barrier and signaling platform built on a lipid bilayer with two nonequivalent faces—exoplasmic and cytoplasmic— bearing proteins, carbohydrates, and a subjacent cortical cytoskeleton [20]. Far from a uniform “fluid mosaic,” contemporary work shows a compositionally and physically heterogeneous membrane that varies across cell types, organelles, and nanoscale microdomains [21,22]. Hundreds of lipid species—glycerophospholipids, sphingolipids, glycolipids, and cholesterol—differ in headgroup charge and hydrogen-bonding, acyl-chain length and unsaturation, and sterol content, together defining packing, viscosity, thickness, curvature, and surface charge [23,24].

A defining attribute is transverse asymmetry. The outer leaflet is enriched in phosphatidylcholine and sphingomyelin and is more tightly packed, whereas the inner leaflet contains more phosphatidylethanolamine and anionic phospholipids such as phosphatidylserine, producing higher negative surface charge and greater unsaturation and fluidity (Figure 1a) [25,26]. ATP-dependent flippases and floppases maintain this organization, and scramblases can transiently relax it during signaling, apoptosis, and membrane remodeling [27]. Cholesterol may also be asymmetric and buffer phospholipid imbalances, with consequences for mechanics and shape.

Figure 1. Molecular diversity of membrane lipids and ion channels. (a) Schematic of major membrane lipids: PC (phosphatidylcholine), PE (phosphatidylethanolamine), PS (phosphatidylserine), SP (sphingomyelin), CHL (cholesterol), and GL (glycolipids). (b) Lipid bilayer illustrating the asymmetric composition of the outer (exoplasmic) and inner (cytoplasmic) leaflets. It also depicts, as an illustrative example: GLIC, a ligand-gated channel (PDB ID: 4NPQ [28]). Molecular graphic was prepared with UCSF ChimeraX (v1.10.1).

Figure 1. Molecular diversity of membrane lipids and ion channels. (a) Schematic of major membrane lipids: PC (phosphatidylcholine), PE (phosphatidylethanolamine), PS (phosphatidylserine), SP (sphingomyelin), CHL (cholesterol), and GL (glycolipids). (b) Lipid bilayer illustrating the asymmetric composition of the outer (exoplasmic) and inner (cytoplasmic) leaflets. It also depicts, as an illustrative example: GLIC, a ligand-gated channel (PDB ID: 4NPQ [28]). Molecular graphic was prepared with UCSF ChimeraX (v1.10.1).

Heterogeneity spans organelles and cell states. Lipidomics now maps organelle-specific lipidomes and their remodeling along the secretory pathway, with membranes becoming progressively thicker, more ordered, and more asymmetric from endoplasmic reticulum to Golgi to plasma membrane [29]. Single-cell lipidomics highlights cell-type variation and adaptive responses to environment [30].

Laterally, membranes host transient nanoscale microdomains—“lipid rafts”—enriched in cholesterol and saturated sphingolipids/glycolipids that sort proteins and lipids [12]. Label-free cryo-EM has visualized coexisting nanodomains in biomimetic and cell-derived membranes, strengthening the physical basis for lateral heterogeneity [31]. Glycosphingolipid acyl-chain structure tunes nanodomain assembly and ligand responses, and rafts participate in vesicle formation and trafficking [32].

Collective lipid composition sets membrane physical properties and thereby the behavior of embedded proteins. Cholesterol increases order and bending rigidity and typically thickens bilayers; multiscale experiments and simulations reconcile earlier discrepancies by showing scale-dependent stiffening of unsaturated membranes and unified elastic behavior at mesoscopic scales [33]. Polyunsaturated chains lower packing and viscosity, thin the hydrophobic core, and reshape lateral stress; ordered lipids and cholesterol do the opposite [34]. Interleaflet coupling allows outer-leaflet order to propagate to the inner leaflet, coordinating bilayer responses [35]. Together, surface charge, dipole potential, lateral pressure, curvature elasticity, chain order, and thickness constitute a “functional paralipidome” that tunes membrane protein structure, localization, and activity [22].

For ion channels, the membrane is an allosteric regulator: hydrophobic mismatch biases conformational states; surface charge and dipole potential shape voltage-sensor energetics; lateral stress and curvature couple to mechanosensitivity; and domain partitioning influences clustering, trafficking, and lipid cofactor availability [22,24]. Thus, membrane chemistry and physics—set by a diverse lipidome, asymmetric architecture, organelle context, and dynamic microdomains—are key determinants of ion channel function.

3. Molecular Diversity of Ion Channels

Ion channels are pore-forming membrane proteins that allow selective, rapid movement of ions (Na⁺, K⁺, Ca²⁺, Cl⁻, and others) down electrochemical gradients. They populate both the plasma membrane and intracellular organelles, and they underlie bioelectric signaling in excitable and non-excitable tissues alike (Figure 1b) [36,37].

Channels open (gate) in response to diverse stimuli. Voltage-gated channels (Nav, Cav, Kv) use the S4 voltage sensor to couple membrane depolarization to opening, whereas ligand-gated channels open when neurotransmitters bind orthosteric sites (pLGICs such as GABA_AR, nicotinic AChR; iGluRs; P2X) [37]. Mechanosensitive channels like PIEZO convert membrane tension into gating transitions [38,39]. Members of the Transient Receptor Potential (TRP) superfamily respond to temperature, lipids, and chemicals, expanding sensory range [40].

Physiologically, ion channels generate and shape action potentials, mediate fast synaptic transmission, control pacemaking, excitation–contraction coupling, hormone secretion, epithelial transport, cell-volume regulation, and sensory transduction; their dysfunction (channelopathies) spans neurology, cardiology, immunology, and cancer biology [37,41].

Molecularly, channels are strikingly diverse. IUPHAR/NC-IUPHAR catalogues voltage-gated-like (VGL) families (Kv, Cav, Nav, HCN, CNG, TRP), ligand-gated families (pLGICs, iGluRs, P2X), and “other” channels (e.g., ClC, ORAI/CRAC, CALHM, TPC, bestrophins) with distinct architectures (tetramers, pentamers, trimers) and gating mechanisms [37]. Collectively, more than 300 human ion channel genes have been identified, depending on whether one counts only pore-forming subunits or also auxiliary/regulatory genes [42,43]. Organelle channels further expand the “channelome,” e.g., mitochondrial MRS2 (Mg²⁺), lysosomal TPCs (Na⁺), and endomembrane ClC/ORAI systems [36,44].

A comprehensive understanding of ion channels now draws on convergent electrophysiological, biochemical, and structural approaches. Electrophysiology remains foundational: patch-clamp recording—in cell-attached, inside-out, outside-out, and whole-cell configurations—resolves single-channel events, conductance, and gating kinetics with millisecond precision [45]. Dynamic clamp augments these measurements by injecting real-time, computationally defined currents into native or engineered cells to test causal hypotheses about channel function within intact circuits [46]. High-throughput automation further scales these assays for pharmacological profiling and clinical variant interpretation, enabling systematic screens across large channel panels [47].

Complementary biochemical and molecular strategies—site-directed mutagenesis, heterologous expression, and reconstitution into controlled lipid environments—map subunit composition, delineate regulatory partners, and parse allosteric mechanisms. Most recently, advances in cryo-electron microscopy and cryo-electron tomography have transformed the field by delivering near-atomic structures across defined functional states. These data illuminate gating trajectories and drug-binding modes for diverse channel families, including mechanosensitive PIEZO channels, pentameric ligand-gated ion channels (pLGICs), and CLC transporters, among others [39,48]. The resulting structural insights increasingly enable structure-guided discovery, informing rational modulator design and the mechanistic interpretation of disease-associated variants [42].

4. Membrane Lipids Modulate Ion Channel Function

The plasma membrane is not a passive backdrop for ion channels; it is a chemically diverse and mechanically active environment that can tune channel gating, permeation, trafficking, and signaling. In most mammalian cells, four lipid families dominate both abundance and functional impact: phospholipids (including phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, and the phosphoinositides), glycolipids (mainly glycosphingolipids such as gangliosides and sulfatide), sphingolipids (sphingomyelin and ceramide), and cholesterol. These components are distributed asymmetrically between leaflets and laterally segregated into microdomains, creating local differences in thickness, curvature, surface charge, and lipid-protein contact chemistry. Conceptually, the principal mechanistic modes by which lipids modulate channels comprise (i) obligate lipid cofactors and electrostatic modulation, (ii) specific binding to annular or non-annular pockets, (iii) bilayer-mediated effects (thickness, curvature, lateral stress), and (iv) nanoscale membrane organization (rafts/caveolae). In the following subsections, I summarize the most relevant findings for each major lipid class, whereas Table 1 provides a more detailed compilation of recent and notable reports describing specific lipid–channel pairs, the type of evidence supporting each interaction, and structural information (Protein Data Bank ID) when available.

Table 1. Lipid Modulation of Ion Channel Function.

Lipid Class	Ion Channel	Mechanistic Mode	Evidence	PDBID	REF
Acyl-CoA (lo; lipid metabolism)	TRPV5/TRPV6	II	cryoEM, EP	8FFO	[49]
Anionic PL; inner-leaflet	Pacemaker family	I	EP, MUT	7TJ6; 7TJ7; 7TJ8	[50]
Bilayer pres; PC	MscL	III	EP, RECON, MD	2OAR	[51,52,53]
Cers (C16:0)	Kv1.3	III	EP		[54]
Cholesterol	BK (Slo1)	II	EP, RECON		[55,56]
	Kir2.x	II	EP, MUT		[57]
	Kv1.3	III	EP		[58]
	Orai1	II	MUT, IMG		[59]
	Pentameric ligand-gated ion channels	II	MD, MS		[60,61]
	Piezo1	IV	EP, IMG		[62]
	TRPV2	II	cryoEM, EP	7XEM	[63]
Chol+PIP2	GIRK2/Kir3.2	II	cryoEM, RECON	6XEV	[64]
Chol; (caveolin)	CaV1.2	IV	IMG, BIOCH		[65]
DAG	TRPC3/TRPC6	II	EP		[66]
GM1+GSL	NMDA receptor	IV	PHARM		[67]
LPA; eicosanoid-r	TRPV1	II	EP, MUT, PHARM		[68]
LPC; cone-shaped	TREK-1 (K2P2.1) & TRAAK (K2P4.1)	III	EP		[69]
PA+PE	TREK1 (K2P family)	II	cryoEM, RECON, MUT	8DE7	[70]
PA+PG	KcsA	II	Fluorescence binding/quenching	1K4C	[71]
PG+PA+PS+CL+PIP2	Kir2.1	II	RECON, MUT		[72]
PIP2	GIRK2	I	Xtal, EP	3SYA	[73]
	KCNQ1/KCNE3	I	cryoEM	6V01	[74]
	KCNQ2/3/Kv7.2/7.3	I	EP, PHARM, MODEL		[75,76]
	TRPM8	II	cryoEM, PHARM	6NR3	[77]
	TRPV5	I	cryoEM, EP	6DMU	[78,79]
PIP2; (long-chain)	KATP/Kir6.2/SUR1	II	cryoEM	8TI1	[80]
PIP2; PIP2+secondary analog	Kir2.2	I	Xtal, EP, MUT	3SPI; 5KUM	[80,81]
PS+PC+PE+Chol	CFTR	I	RECON, BIOCH		[82]
PS+PE; headgroup charge	BK/Slo1	I	RECON		[83]
SM+Cer	PIEZO1	III	EP, GEN		[84]
	TRPC6	IV	EP, PHARM, BIOCH, GEN		[85]
SM; SMase D	Orai1/STIM1	IV	EP, IMG		[86]

Abbreviations. Mechanistic mode: (I) obligate lipid cofactors/electrostatics; (II) specific annular or non-annular pocket binding; (III) bilayer-mediated effects (thickness/curvature/lateral stress); (IV) nanoscale membrane organization (rafts/caveolae). Evidence: cryoEM = cryo-electron microscopy; Xtal = X-ray crystallography; EP = electrophysiology; RECON = reconstitution (liposomes/bilayers/nanodiscs); MUT = mutagenesis; MD = molecular dynamics; PHARM = pharmacology; IMG = imaging/localization; BIOCH = biochemical/binding assay; GEN = genetics/clinical variants; MS = mass spectrometry; FRET = Förster resonance energy transfer.

Table 1. Lipid Modulation of Ion Channel Function.

Lipid Class	Ion Channel	Mechanistic Mode	Evidence	PDBID	REF
Acyl-CoA (lo; lipid metabolism)	TRPV5/TRPV6	II	cryoEM, EP	8FFO	[49]
Anionic PL; inner-leaflet	Pacemaker family	I	EP, MUT	7TJ6; 7TJ7; 7TJ8	[50]
Bilayer pres; PC	MscL	III	EP, RECON, MD	2OAR	[51,52,53]
Cers (C16:0)	Kv1.3	III	EP		[54]
Cholesterol	BK (Slo1)	II	EP, RECON		[55,56]
	Kir2.x	II	EP, MUT		[57]
	Kv1.3	III	EP		[58]
	Orai1	II	MUT, IMG		[59]
	Pentameric ligand-gated ion channels	II	MD, MS		[60,61]
	Piezo1	IV	EP, IMG		[62]
	TRPV2	II	cryoEM, EP	7XEM	[63]
Chol+PIP2	GIRK2/Kir3.2	II	cryoEM, RECON	6XEV	[64]
Chol; (caveolin)	CaV1.2	IV	IMG, BIOCH		[65]
DAG	TRPC3/TRPC6	II	EP		[66]
GM1+GSL	NMDA receptor	IV	PHARM		[67]
LPA; eicosanoid-r	TRPV1	II	EP, MUT, PHARM		[68]
LPC; cone-shaped	TREK-1 (K2P2.1) & TRAAK (K2P4.1)	III	EP		[69]
PA+PE	TREK1 (K2P family)	II	cryoEM, RECON, MUT	8DE7	[70]
PA+PG	KcsA	II	Fluorescence binding/quenching	1K4C	[71]
PG+PA+PS+CL+PIP2	Kir2.1	II	RECON, MUT		[72]
PIP2	GIRK2	I	Xtal, EP	3SYA	[73]
	KCNQ1/KCNE3	I	cryoEM	6V01	[74]
	KCNQ2/3/Kv7.2/7.3	I	EP, PHARM, MODEL		[75,76]
	TRPM8	II	cryoEM, PHARM	6NR3	[77]
	TRPV5	I	cryoEM, EP	6DMU	[78,79]
PIP2; (long-chain)	KATP/Kir6.2/SUR1	II	cryoEM	8TI1	[80]
PIP2; PIP2+secondary analog	Kir2.2	I	Xtal, EP, MUT	3SPI; 5KUM	[80,81]
PS+PC+PE+Chol	CFTR	I	RECON, BIOCH		[82]
PS+PE; headgroup charge	BK/Slo1	I	RECON		[83]
SM+Cer	PIEZO1	III	EP, GEN		[84]
	TRPC6	IV	EP, PHARM, BIOCH, GEN		[85]
SM; SMase D	Orai1/STIM1	IV	EP, IMG		[86]

Abbreviations. Mechanistic mode: (I) obligate lipid cofactors/electrostatics; (II) specific annular or non-annular pocket binding; (III) bilayer-mediated effects (thickness/curvature/lateral stress); (IV) nanoscale membrane organization (rafts/caveolae). Evidence: cryoEM = cryo-electron microscopy; Xtal = X-ray crystallography; EP = electrophysiology; RECON = reconstitution (liposomes/bilayers/nanodiscs); MUT = mutagenesis; MD = molecular dynamics; PHARM = pharmacology; IMG = imaging/localization; BIOCH = biochemical/binding assay; GEN = genetics/clinical variants; MS = mass spectrometry; FRET = Förster resonance energy transfer.

4.1. Phospholipids: Headgroups, Acyl Chains, and Phosphoinositides as Gating Cofactors

Phospholipids provide most of the membrane’s surface area, and their influence on ion channels spans two scales. At the bulk scale, headgroup chemistry and acyl-chain saturation tune bilayer thickness, lateral pressure, and elasticity, which can bias conformational equilibria of embedded proteins. At the specific scale, certain phospholipids act as bona fide ligands or cofactors that bind to defined sites and stabilize particular channel states, often coupling receptor signaling to excitability.

Phosphoinositides—especially PI(4,5)P₂ (PIP2)—are unusually potent regulators because their polyanionic headgroups bind basic channel surfaces and stabilize activatable conformations. For G protein-gated inward rectifier K+ channels (GIRKs), Whorton and MacKinnon solved crystal structures of mammalian GIRK2 and demonstrated how PIP2 binding couples a cytoplasmic “G-loop” gate to an inner-helix gate, allowing coordinated opening transitions that are inefficient without the lipid (Figure 2) [73]. The same conceptual mechanism has been reinforced by later cryo-EM work showing how PIP2 shifts the GIRK conformational ensemble toward a “docked” architecture consistent with activation [87].

In classical Kir channels, the same permission-signal logic is supported by a deep body of patch-clamp work and continues to be refined structurally. An atomistic study of Kir2.2 opening and conduction, paired with simulations, illustrates how opening at the inner-helix bundle crossing and stabilization of a conductive pore can be parsed at the residue level—an essential framework for mapping how lipid-bound interfaces bias open probability and rectification behavior [88]. Although Kir2.2 gating involves additional factors (e.g., cytosolic polyamines in rectification), these structural approaches enable mechanistic questions to be asked precisely: which basic residues coordinate PIP2 phosphates, how those contacts propagate to the cytoplasmic domain, and how lipid occupancy reshapes the energetic coupling between domains.

The neuronal M-current (KCNQ2/3; Kv7.2/7.3) is a canonical case where receptor-driven PIP2 depletion suppresses excitability. Zhang and colleagues demonstrated that PIP2 activates KCNQ channels and that PIP2 hydrolysis is sufficient to inhibit them, explaining muscarinic suppression of the M current as a lipid-dependent gating process [75]. Falkenburger et al. then quantified the kinetics of PIP2 metabolism and KCNQ2/3 regulation, concluding that PIP2 activation is cooperative and that residence/exchange kinetics can be fast enough to support rapid neuromodulation [76]. Together, these primary studies define a general logic now seen across many channels: GPCR→PLC signaling is not merely “second messenger chemistry,” but a lipid-remodeling event that removes an essential cofactor from a channel and thereby alters excitability.

Phosphoinositide regulation extends to TRP channels but is often subtype-specific in sign and state dependence. For the cold/menthol receptor TRPM8, Rohács et al. demonstrated that PI(4,5)P2 is required for activation by cold and menthol; depletion of PIP2 markedly reduced TRPM8 activity, providing a direct molecular link between PLC activation and desensitization of cold sensation [89]. For the heat/capsaicin receptor TRPV1, early primary work identified a C-terminal region required for PIP2-mediated inhibition of channel activity, motivating the idea that phosphoinositides can act as “brakes” or “permits” depending on channel and context [90].

Recent structural work has moved beyond inferred binding to direct visualization of lipid occupancy in TRPV1. Cryo-EM studies captured TRPV1 in multiple states with endogenous or added bioactive lipids—including phosphoinositide species and lysophospholipids—occupying the vanilloid binding pocket, clarifying how different endogenous lipids can stabilize distinct functional states [91]. This matters for membrane biology because it connects classic physiology (sensitization/desensitization) to a testable structural hypothesis: lipid identity and occupancy in a defined pocket can bias TRPV1 toward open, closed, or sensitized conformations.

Phospholipid regulation is not only about headgroups; acyl-chain composition and free fatty acids can modulate channels by altering bilayer mechanics and by interacting with defined channel motifs. In the IKs complex (KCNQ1/KCNE1), PUFA analogs can activate the channel via defined determinants, supporting electrostatic coupling between lipid headgroups and gating machinery [92]. Such findings complement broader biophysical ideas (e.g., membrane elasticity affecting mechanosensitivity) by providing molecular determinants that can be mutated and tested.

4.2. Sphingolipids: Sphingomyelin/Ceramide Remodeling and Sphingolipid Metabolites

Sphingolipids, enriched in the outer leaflet, promote ordered membrane phases and interact strongly with cholesterol. Their regulation of channels often emerges from enzymatic remodeling—especially conversion of sphingomyelin to ceramide—creating ceramide-rich platforms that reorganize membrane proteins and signaling assemblies.

4.2.1. Ceramide Platforms and Kv1.3

A foundational primary report linked ceramide to inhibition of the voltage-gated K+ channel Kv1.3 and connected this inhibition to the formation of ceramide-rich platforms, providing early mechanistic evidence that lipid remodeling can control channel function through mesoscale membrane reorganization [93]. This “platform” mechanism is especially relevant in immune and apoptotic signaling, where ceramide production is a common stress response.

4.2.2. Sphingomyelinase Disables Piezo1 Inactivation: Sustained Mechanotransduction

One of the most compelling recent examples of sphingolipid control involves mechanosensitive Piezo1 channels. Shi et al. demonstrated that sphingomyelinase activity disables inactivation in endogenous Piezo1 currents; altering the sphingomyelin/ceramide balance shifted native Piezo gating toward sustained activity and enabled prolonged endothelial responses to mechanical stimulation [84]. This result is powerful because it identifies a lipid-enzyme switch that can convert a “transient mechanosensor” into a “sustained mechanotransducer,” a property that has obvious physiological implications for flow sensing and vascular tone.

4.2.3. Ceramide Effects Beyond Platforms: Direct State Biasing

In addition to platform-level reorganization, ceramides can bias gating energetics more directly at the membrane–water interface. A recent report showed that membrane-loaded C16-ceramide shifted Kv1.3 activation to more positive voltages and slowed activation kinetics, consistent with ceramide influencing voltage-sensor–pore coupling and/or directly contacting the channel in a way that alters the energy landscape of activation [54]. This complements earlier platform-based interpretations by emphasizing that ceramide can tune channel kinetics even when gross membrane clustering is not the only factor.

4.2.4. Sphingosine as a Direct Inhibitor: TRPM7

Sphingolipid metabolites can also act like classical ligands. TRPM7, a channel-kinase central to Mg2+ homeostasis, is potently inhibited by sphingosine and the sphingosine analog FTY720. A primary electrophysiological study demonstrated robust TRPM7 inhibition consistent with direct modulation in excised patches, linking a defined sphingolipid metabolite to a ubiquitous cation pathway [94]. Such findings highlight that sphingolipid metabolism is not just structural remodeling; it also generates small-molecule modulators that can directly gate or block channels.

4.2.5. TRPC6 Ca2+ Entry and Sphingomyelinase

Sphingolipid remodeling can modulate TRP-channel signaling by changing the local membrane environment and/or generating bioactive sphingolipid species. In neuronal systems, acid sphingomyelinase (ASM) activity was shown to regulate TRPC6-mediated Ca²⁺ influx in response to hyperforin, linking sphingomyelin/ceramide metabolism to receptor-independent TRPC6 activation and downstream Ca²⁺ signaling [95]. Consistent with this mechanism, subsequent work further supported that balanced ASM-dependent sphingolipid metabolism is important for robust TRPC6 function and Ca²⁺ signaling in related cellular contexts [85].

4.3. Glycolipids: Gangliosides and Sulfatide as Modulators and Organizers of Excitability

Glycolipids are concentrated in neuronal and epithelial membranes and present bulky, often negatively charged carbohydrate headgroups on the extracellular leaflet. These headgroups can alter surface electrostatics, hydration forces, and microdomain partitioning, and they can provide specific binding epitopes for extracellular proteins. As a result, glycolipids can influence ion channels through both local physical effects and more specific “glycan-recognition” mechanisms.

4.3.1. GM1 Ganglioside and Ca2+ Entry

A primary demonstration linking a defined ganglioside to Ca2+ entry used the GM1-binding cholera toxin B subunit in N18 neuroblastoma cells. Carlson et al. showed that binding to endogenous GM1 triggered a sustained rise in intracellular Ca2+ that required extracellular Ca2+ and was blocked by nickel, consistent with GM1-dependent modulation of Ca2+-permeable channel activity and/or channel coupling to membrane signaling complexes [96]. This experiment established that manipulating a single ganglioside in the outer leaflet can rapidly alter Ca2+-entry phenotypes.

4.3.2. Gangliosides Tune Voltage-Gated Na+ Channel Excitability

Glycolipids can also influence classical voltage-gated channels. A primary report showed that the ganglioside GD1a increases the excitability of voltage-dependent sodium channels, implying that defined ganglioside species can shift NaV functional properties and thereby tune neuronal firing [97]. Mechanistically, such effects could arise from altered electrostatics near extracellular channel surfaces, changes in local membrane order, or partitioning of channels into glycosphingolipid-enriched nanodomains.

4.3.3. Sulfatide Stabilizes Nodal Channel Clusters In Vivo

Perhaps the most compelling systems-level evidence for glycolipid control of ion channels comes from myelinated axons. Ishibashi et al. examined mice deficient in sulfatide synthesis and found that sulfatide is essential for maintenance of ion channel clusters on myelinated axons, although it is not required for initial cluster formation [98]. This directly links a specific glycolipid to the spatial architecture of excitability: in the absence of sulfatide, the long-term stability of nodal/paranodal organization is impaired, which is expected to degrade saltatory conduction even if channels can initially cluster.

4.3.4. Glycolipid-Dependent Raft Signaling to TRPC6 via Soluble α-Klotho

Glycolipids also participate in raft-based signaling that controls channel abundance. Dalton et al. discovered that soluble α-klotho binds monosialogangliosides in lipid rafts and modulates microdomain structure and growth factor signaling, establishing a mechanism by which an endocrine factor can “read” ganglioside glycans and reshape raft organization [99]. Building on this, Wright et al. showed that soluble klotho regulates TRPC6 Ca2+ signaling via lipid rafts, providing a direct bridge from ganglioside binding to control of ion channel-dependent Ca2+ entry [100]. These studies underscore that glycolipids can influence channels not only through local physical effects, but also by serving as specific recognition elements in signaling circuits that regulate channel surface expression and insertion.

4.4. Cholesterol: Direct Binding, Stereospecific Recognition, and Microdomain Mechanics

Cholesterol is abundant in animal plasma membranes and can regulate channels through direct binding and by shaping microdomain organization. A striking example of direct binding comes from TRPV2. Cryo-EM revealed an endogenous cholesterol molecule occupying the vanilloid binding pocket and acting as an inhibitory lipid, demonstrating that cholesterol can function as a resident ligand with allosteric control over gating (Figure 3) [63]. This kind of evidence matters because it constrains mechanistic interpretation: if a sterol occupies a defined pocket, then at least part of its effect must be explained by protein–sterol recognition rather than solely by changes in membrane stiffness or thickness.

Cholesterol can also influence complex functional transitions. For TRPV1, Jansson et al. found that cholesterol depletion inhibited pore dilation-associated behavior and reduced permeability increases during sustained agonist activation, suggesting that sterol content affects not only opening but also higher-conductance or altered-permeation states [101]. In parallel, TRPV1 cryo-EM work capturing bioactive lipid occupancy in the vanilloid pocket provides a structural framework for how different lipids (including sterol-related effects indirectly) can bias gating and sensitization [91].

Kir2 channels are among the best characterized for cholesterol sensitivity at the residue level. A primary PNAS study mapped cholesterol sensitivity of Kir2.1 to a specific C-terminal CD loop region, showing that defined cytosolic elements determine whether cholesterol suppresses channel activity [102]. Subsequent primary work proposed a cytosolic “belt” of residues that collectively controls cholesterol sensitivity [103]. These observations support an important idea: cholesterol can regulate channels through nonannular, stereochemically selective interactions that are encoded in protein architecture, not just membrane material properties.

Cholesterol also regulates channels by organizing them into membrane domains. For Piezo1, Ridone et al. demonstrated that cholesterol organizes Piezo1 into membrane domains; disrupting cholesterol altered channel clustering and shifted mechanosensitive responses, changing the functional output of mechanical stimulation [62]. This provides an instructive complement to sphingomyelinase/ceramide control of Piezo1 inactivation: mechanosensation can be tuned both by lipid enzymology (changing inactivation) and by sterol-dependent spatial organization (changing clustering/force response).

BK channels provide an unusually clear set of primary examples showing that cholesterol can regulate the same channel through distinct mechanisms depending on experimental context. In reconstituted phospholipid bilayers, Bukiya et al. found that cholesterol reduces BK open probability and does so stereospecifically: neither epicholesterol nor ent-cholesterol reproduced the inhibition, strongly supporting a specific sterol–protein recognition mechanism rather than a purely bilayer-mediated effect [56]. In contrast, in vascular smooth muscle cells, cholesterol enrichment can shift the net effect toward BK activation through a time-dependent, trafficking-mediated increase in surface KCNMB1 (β1) subunits; notably, acute cholesterol loading of isolated membrane patches inhibits BK, whereas prolonged enrichment in intact myocytes activates BK and requires β1 and forward trafficking [55]. Together, these studies caution against overgeneralization: cholesterol can act as a direct inhibitory ligand in simplified systems, yet function as a cell-biological regulator of BK channel composition and surface availability in intact cells.

4.5. Concluding Synthesis

Across lipid families, primary research converges on three experimentally actionable principles. First, some lipids behave as required cofactors or endogenous ligands: PIP2 licenses gating and gate coupling in multiple channels (e.g., GIRK; [73]), and bioactive lysophospholipids can directly activate pain-relevant channels (LPA→TRPV1; [68]). Second, lipid metabolism can act as a switch for channel kinetics and adaptation, as seen in sphingomyelinase/ceramide control of Piezo1 inactivation [84]. Third, lateral organization matters: glycolipids and cholesterol can control where channels reside, how stably they cluster, and whether they are inserted or retained at the membrane (e.g., sulfatide-dependent maintenance of axonal channel clusters; [98]; and cholesterol-dependent Piezo1 domains [62]. Together, these mechanisms connect molecular binding and membrane physics to cell-level excitability and sensory physiology—explaining why changing membrane lipid composition can be as consequential for ion channel function as changing the channel’s own amino-acid sequence.

5. Bioactive Lipids as Modulators of Ion Channels

“Bioactive lipids” is an umbrella term for endogenous lipid species that act as signaling mediators. They are typically generated on demand by tightly regulated enzymes and remodeled or degraded on short time scales. In contrast to bulk “structural” membrane lipids, bioactive lipids are often low abundance and spatially restricted (e.g., confined to a leaflet, an organelle contact site, or a nanodomain), yet can engage specific protein targets through direct binding or via receptor- and enzyme-coupled cascades [76,77]. Their diversity is substantial: modern lipidomics platforms can quantify hundreds of signaling lipids spanning multiple classes (phosphoinositides, lysophospholipids, diacylglycerols, phosphatidic acid, sphingolipids, fatty acids/oxylipins, and related derivatives), underscoring that “bioactive lipids” refers to a functional role rather than a single structural family [78,79].

Within this landscape, several classes are particularly relevant to membrane excitability and transport. Phosphoinositides (PIPs)—notably PI(4,5)P2 and PI(3,4,5)P3—function as anionic cofactors that couple receptor stimulation (e.g., PLC/PI3K pathways) to channel gating [80]. Diacylglycerol (DAG) (and related monoacylglycerols, MAGs) serves as a canonical second messenger downstream of PLC, classically linked to PKC but also capable of directly gating channels (e.g., DAG-sensitive TRPCs) [81]. PA stands for phosphatidic acid, a lipid messenger generated by PLD or DGK that can regulate membrane curvature and recruit protein domains, and (in several cases) modulate ion channels [55]. Lysophospholipids (LPLs) such as LPA and LPC are “single-tailed” lipids with strong biophysical effects and, in select cases, well-defined direct channel targeting [75]. Finally, sphingolipids (including ceramides) are widely recognized as bioactive lipids because they can be generated acutely (e.g., sphingomyelinase pathways), signal through dedicated effectors, and modulate membrane proteins including ion channels [59].

Bioactive lipids influence ion channels through four principal (often overlapping) mechanistic modes:

• Obligate cofactor/electrostatic control, where anionic lipids—especially PIPs—“license” gating and gate coupling by stabilizing permissive conformations [80].
• Specific binding to annular or non-annular pockets (including fenestrations) that allosterically reshape gating energetics; an increasing number of structures and structure-guided studies now map these interactions at residue-level precision [82].
• Bilayer-mediated effects, where lipid shape and packing (thickness, curvature, lateral stress) bias channel energetics—particularly relevant for single-tailed LPLs and mechanosensitive channels [83].
• Nanoscale membrane organization (rafts/caveolae and other microdomains) that co-clusters channels with partners, controls local lipid pools, and integrates lipid signaling with trafficking and phosphorylation cascades [80].

Because these modes recur across many unrelated channel families, lipids provide a versatile regulatory layer superimposed on voltage-, ligand-, and force-dependent gating. In the following subsections, I summarize representative channel–lipid interactions organized by lipid class, whereas Table 2 compiles the most notable and recent primary reports in a cross-referenced format.

Table 2. Bioactive lipids that affect ion channel activity.

Bioactive Lipid	Ion Channel	Effect	Mechanism	References
Anandamide (AEA)	TRPV1	Direct activation (gating)	Lipid-access path; allosteric pocket (peripheral)	[104]
Lysophosphatidic acid (LPA)	TRPV1	Direct activation; pain in vivo	C-terminal lysine binding	[68]
20-HETE (eicosanoid)	TRPV1	Activation & sensitization	Direct/indirect modulation; promotes nociception	[105]
Prostaglandins (PGE2, PGI2)	TRPV1	Sensitization (↓ heat threshold)	EP/IP GPCRs → PKA/PKC signaling	[106,107]
4-Hydroxynonenal (4-HNE)	TRPA1	Covalent activation	Electrophile adduction to cysteines	[108]
Arachidonic acid & other PUFAs; LPC	TRPM8	PUFAs inhibit; LPC potentiates	Allosteric effects on gating by cold/menthol	[109]
5,6-EET (epoxyeicosatrienoic acid)	TRPV4	Activation	EET-binding pocket; key residues (e.g., K535)	[110,111]
Diacylglycerol (DAG)	TRPC3/6	Direct activation	Membrane-delimited, PKC-independent	[66]
Arachidonic acid (AA), LPC, LPA	K2P (TREK-1/2, TRAAK)	Activation/gating to leak	Inner-leaflet lipid sensing; intracellular LPA gating	[69,112]
PUFAs (e.g., DHA analogs)	Kv7/KCNQ1 (IKs)	Activation; V½ shift; rescue of LQTS	Interactions near VSD/pore; subtype-specific	[113]
Ceramide	Kv1.3	Inhibition	Ceramide platforms/rafts; clustering	[93,114]
Sphingosine-1-phosphate (S1P)	BK (KCa1.1)	Activation; hyperpolarization	GPCR-dependent/independent reports; cell-type specific	[115]
Anandamide; lipoamino acids	Cav3.x (T-type)	Inhibition (CB-independent)	Stabilizes inactivated states; direct block	[116]
Endocannabinoids (AEA/2-AG)	Cav2.2 (N-type)	Inhibition	CB1→Gβγ→Cav2.2 inhibition; retrograde control	[117]
PUFAs (composition); PA/LPA	Piezo1/2	Piezo1 sensitivity tuned; PIEZO2 inhibited	Bilayer-mechanics tuning; PLD→PA signaling for PIEZO2	[118]

Table 2. Bioactive lipids that affect ion channel activity.

Bioactive Lipid	Ion Channel	Effect	Mechanism	References
Anandamide (AEA)	TRPV1	Direct activation (gating)	Lipid-access path; allosteric pocket (peripheral)	[104]
Lysophosphatidic acid (LPA)	TRPV1	Direct activation; pain in vivo	C-terminal lysine binding	[68]
20-HETE (eicosanoid)	TRPV1	Activation & sensitization	Direct/indirect modulation; promotes nociception	[105]
Prostaglandins (PGE2, PGI2)	TRPV1	Sensitization (↓ heat threshold)	EP/IP GPCRs → PKA/PKC signaling	[106,107]
4-Hydroxynonenal (4-HNE)	TRPA1	Covalent activation	Electrophile adduction to cysteines	[108]
Arachidonic acid & other PUFAs; LPC	TRPM8	PUFAs inhibit; LPC potentiates	Allosteric effects on gating by cold/menthol	[109]
5,6-EET (epoxyeicosatrienoic acid)	TRPV4	Activation	EET-binding pocket; key residues (e.g., K535)	[110,111]
Diacylglycerol (DAG)	TRPC3/6	Direct activation	Membrane-delimited, PKC-independent	[66]
Arachidonic acid (AA), LPC, LPA	K2P (TREK-1/2, TRAAK)	Activation/gating to leak	Inner-leaflet lipid sensing; intracellular LPA gating	[69,112]
PUFAs (e.g., DHA analogs)	Kv7/KCNQ1 (IKs)	Activation; V½ shift; rescue of LQTS	Interactions near VSD/pore; subtype-specific	[113]
Ceramide	Kv1.3	Inhibition	Ceramide platforms/rafts; clustering	[93,114]
Sphingosine-1-phosphate (S1P)	BK (KCa1.1)	Activation; hyperpolarization	GPCR-dependent/independent reports; cell-type specific	[115]
Anandamide; lipoamino acids	Cav3.x (T-type)	Inhibition (CB-independent)	Stabilizes inactivated states; direct block	[116]
Endocannabinoids (AEA/2-AG)	Cav2.2 (N-type)	Inhibition	CB1→Gβγ→Cav2.2 inhibition; retrograde control	[117]
PUFAs (composition); PA/LPA	Piezo1/2	Piezo1 sensitivity tuned; PIEZO2 inhibited	Bilayer-mechanics tuning; PLD→PA signaling for PIEZO2	[118]

5.1. Class-Specific Highlights with Recent Mechanistic Anchors

5.1.1. Phosphoinositides (PIPs): Anionic Cofactors and Structural Determinants of Gating

Among bioactive lipids, PIPs are arguably the most pervasive channel regulators because they combine: (i) fast enzymatic control (PI kinases/phosphatases; PLC), (ii) strong electrostatic coupling to basic residues in channels and auxiliary subunits, and (iii) microdomain localization that concentrates signaling at defined membrane regions. A recent synthesis focusing on TRP channels emphasizes that PIP regulation often reflects a balance between direct anionic cofactor binding and indirect pathway effects, and that the same lipid can be permissive in one channel context yet inhibitory in another depending on subunits and state occupancy [119].

Mechanistic progress is increasingly driven by convergent structure–function strategies. For TRPC3, a 2024 study combining coarse-grained simulations, mutagenesis and electrophysiology localized PI(4,5)P2 binding to a defined pocket (“L3”), and linked this interaction to the TRP helix/S4–S5 linker network that couples ligand-binding and pore opening. This provides a concrete example of how PIPs can act as allosteric ligands rather than generic membrane components [120,121].

PIP-mediated inhibition is also increasingly understood at structural resolution. In the cyclic nucleotide-gated channel SthK, cryo-EM in nanodiscs resolved a PI(4,5)P2 density bridging key structural elements and supported a model in which PIP2 can stabilize a closed/resting configuration, thereby reducing open probability. Although SthK is bacterial, the study is conceptually important because it illustrates how PIPs can “lock” specific conformations through bridging interactions across domains [122].

Finally, lipid densities observed in TRP structures can represent functionally meaningful occupancy states. For TRPV1, recent structural work described an endogenous lipid density in the vanilloid pocket, integrating lipid displacement/occupancy into mechanistic schemes of activation and inhibition. This reinforces the notion that “lipid modulation” can occur via site occupancy that competes with or reshapes the action of exogenous ligands [121].

5.1.2. Diacylglycerol (DAG) and Related Glycerolipids: Direct Gating and Defined Binding Sites

DAG is a central second messenger produced by PLC-mediated PI(4,5)P2 hydrolysis. Its role in channel regulation is exemplified by the TRPC3/6/7 subfamily, where DAG can activate channels in a largely membrane-delimited manner. The foundational demonstration that DAG directly activates human TRPC6 and TRPC3 (independent of PKC) remains a reference point for defining “direct lipid gating” in mammalian channels [66].

Recent work is now resolving where and how DAG binds. A 2025 structural study presented TRPC3 complexes with DAG and synthetic activators, mapping lipid occupancy to a defined site and supporting competitive binding at a functionally critical pocket. Such data shift the field from “DAG sensitivity” as a phenomenological label to site-resolved, testable models for lipid-driven activation [123].

A particularly powerful recent direction is the use of photoswitchable DAG analogs. These tools enable optical control of lipid conformation and timing, permitting measurements of activation/deactivation kinetics that are otherwise difficult to access with enzymatic stimulation. A 2024 electrophysiological analysis of photoswitchable TRPC6 activators reported ligand-specific kinetic signatures, consistent with distinct active-state ensembles. Beyond providing mechanistic insight, such approaches illustrate how bioactive lipid signaling can be interrogated with near-single-channel temporal precision [124,125].

5.1.3. Phosphatidic Acid (PA): Linking Lipid Metabolism to Mechanotransduction and K2P Gating

PA (phosphatidic acid) occupies a unique position among bioactive lipids because it is both a metabolic hub and a signaling lipid with strong biophysical effects (shape/curvature). PA is generated prominently by phospholipase D (PLD) or via diacylglycerol kinases (DGKs), providing multiple entry points for receptor-coupled regulation.

Mechanistically informative recent studies connect PA to both mechanosensitive and leak channels. For PIEZO2, a 2024 study using optogenetic and biochemical manipulation of PLD2/PA identified PA as a negative regulator of mechanically activated PIEZO2 currents, thereby linking lipid metabolism directly to mechanotransduction [118].

For K2P channels, mechanistic work has emphasized that phospholipid headgroup chemistry and lipid occupancy states tune the gating landscape. A 2023 study dissected how membrane phospholipids control gating of the mechanosensitive potassium leak channel TREK1, providing a framework in which specific lipid interactions (including PA-relevant pathways) stabilize functional states and reshape energetic coupling between force sensing and pore opening [126].

Together, these findings support a unifying view: PA can regulate channels both by direct/semidirect lipid interactions and by local remodeling of the bilayer environment, making it a plausible integrator of enzymatic signaling and mechanical responsiveness [118].

5.1.4. Lysophospholipids (LPLs): Direct Lipid Gating, Fenestrations, and Pain-Relevant Signaling

Lysophospholipids (LPLs) such as LPA and LPC are potent bioactive mediators with strong biophysical “wedge” properties and extensive receptor signaling. Importantly, select cases demonstrate receptor-independent, direct channel targeting. LPA directly activates TRPV1 by binding an intracellular site (C-terminus), establishing a clear precedent for direct gating of a mammalian ion channel by a lysophospholipid [68].

LPC has also emerged as a direct or semidirect modulator in multiple contexts. A 2024 study showed that LPC-induced activation of TRPC5 depends on conserved residues within a lateral fenestration and is modulated by voltage and xanthine ligands, illustrating how LPLs can exploit transmembrane access pathways to influence gating [127].

A clinically relevant line of evidence links a defined LPC species (LPC16:0) to ASIC3-dependent persistent pain phenotypes. Studies in humans and rodent models support LPC16:0 as an endogenous lipid modulator that can drive long-lasting pain and anxiety-like behavior through Acid-Sensing Ion Channel 3 (ASIC3)-dependent mechanisms, including osteoarthritic pain contexts [128].

Most recently, LPLs were identified as endogenous activators of pannexin channels. A 2025 study combining activity-guided fractionation, metabolomics and electrophysiology reported that lysophospholipids directly and reversibly activate PANX1, linking lipid signals to ATP release and downstream immunomodulatory pathways. This extends the scope of LPL action from canonical GPCR signaling and sensory channels to ATP-release conduits that interface with inflammation [129].

5.1.5. Sphingolipids (Including Ceramides): Bona Fide Bioactive Lipids That Remodel Channel Gating

Ceramides are unequivocally considered a class of bioactive lipids, given their regulated generation (e.g., sphingomyelinase routes), signaling roles, and capacity to alter protein function and membrane organization. In ion channel biology, mechanistic evidence has strengthened markedly in recent years.

For Kv1.3, a 2024 study used voltage-clamp fluorometry to show that membrane ceramides and glucosylceramides reshape activation gating through combined intramolecular effects (voltage sensor–pore coupling) and membrane-depth properties, providing a clear biophysical mechanism for sphingolipid modulation [54].

For hERG1 (Kv11.1), a 2021 study integrated simulations and mutagenesis to identify ceramide-specific binding locations at the interface between pore and voltage-sensing domains, consistent with a defined structural crevice that can support sphingolipid binding and functional block/gating shifts. This illustrates how sphingolipid modulation can be explained by site-specific binding rather than only raft/platform effects [130].

Collectively, these findings reinforce that sphingolipids—especially ceramides—are not peripheral membrane modifiers but can serve as direct gating regulators (or state stabilizers) with well-defined structural correlates.

5.1.6. Fatty Acids and Oxylipins: Rapid Lipid Mediators Intersecting with K2P and TRP Energetics

Although not exhaustive here, fatty acids and their oxidized derivatives (oxylipins) represent an additional layer of bioactive lipid control. For K2P channels, polyunsaturated fatty acids (PUFAs) can activate TREK channels, and recent work supports a direct interaction component that complements membrane-tension-based models of activation [131].

5.2. Summary and Perspective

In sum, bioactive lipids constitute a chemically diverse set of endogenous signals that modulate ion channels through direct binding, bilayer-mediated energetics, and signaling-network control. Recent advances are particularly notable in three areas: (i) site-resolved structural mechanisms for PIP-, DAG-, and ceramide-sensitive channels; (ii) explicit links between lipid metabolic enzymes (e.g., PLD2/PA) and mechanotransduction; and (iii) emerging lipid classes and tools (e.g., photoswitchable DAGs; LPL gating of PANX1) that enable time-resolved and mechanistically discriminating experiments. These trends argue that “lipid modulation of ion channels” is best treated not as an accessory topic but as a central framework for understanding how cells couple metabolism and signaling to excitability and transport [118,119,123,129].

6. Lipid Post-Translational Modification of Ion Channels

Lipid post-translational modifications (PTMs) are covalent additions of lipid moieties to proteins that critically influence their localization, stability, and function at cellular membranes [132]. Unlike integral membrane proteins that span the bilayer via hydrophobic transmembrane segments, many peripheral or signaling proteins—including numerous ion channels and auxiliary subunits—depend on PTMs to associate with membranes and to partition into nanoscale lipid microdomains (rafts/caveolae), thereby tuning trafficking and signal transduction. These modifications increase protein hydrophobicity, target proteins to specific subcellular membranes, and modulate protein–protein and protein–lipid interactions. Contemporary reviews emphasize the diversity and dynamics of lipidation—especially reversible S-acylation—and its broad roles in physiology and disease [133,134,135].

Several major lipid PTMs are recognized. N-myristoylation is a co-translational, generally irreversible amide linkage of myristate (C14:0) to an N-terminal glycine, providing a relatively weak membrane anchor that often cooperates with other signals for stable attachment [136,137]. S-palmitoylation (S-acylation) is the reversible thioester linkage of long-chain fatty acids (typically palmitate, C16:0) to cysteine residues, conferring dynamic control over membrane affinity, nanoscale compartmentalization, trafficking, clustering, and functional modulation of many signaling proteins and channels [133,135,138]. Prenylation—attachment of farnesyl (C15) or geranylgeranyl (C20) isoprenoids to C-terminal cysteines within a CaaX motif—promotes stable membrane association and protein–protein interactions, classically for small GTPases that orchestrate channel trafficking and signaling [139,140]. In addition, glycosylphosphatidylinositol (GPI) anchoring tethers proteins to the outer leaflet of the plasma membrane via a glycolipid, promoting lateral mobility and raft association that can influence multi-protein signaling assemblies impinging on ion channel regulation [141].

These lipid PTMs are not mutually exclusive and frequently act in combination to fine-tune membrane targeting, turnover, and activity. As summarized in Table 3, a growing literature shows that ion channels themselves (not only their signaling partners) are lipidated, with functional consequences. For example, TRPV1 is S-palmitoylated by ZDHHC4, which promotes lysosomal degradation and shapes nociceptor output during inflammatory pain; the depalmitoylase APT1 counterbalances this modification [142]. In epithelia, ENaC β/γ subunits are palmitoylated, with γ-subunit palmitoylation dominantly increasing open probability; specific zDHHC enzymes (1/2/3/7/14) enhance ENaC activity in a palmitoylation-dependent manner, and recent mouse genetics refine the in-vivo picture [143]. In the heart, Nav1.5 palmitoylation increases channel availability and late I_Na, prolonging action potentials—linking lipidation to arrhythmia susceptibility [144]. For K_ATP (Kir6.2/SUR), palmitoylation of Kir6.2 Cys166 increases PIP₂ sensitivity and current, with disease-relevant variants phenocopying the gain-of-function [145]. HCN4 currents are augmented by palmitoylation (via N-terminal bilayer recruitment) [146], and Kv1-family clustering at the axon initial segment depends on ZDHHC14-mediated palmitoylation of PSD93 and Kv1 channels—mechanisms that reshape firing. Broad overviews of channel lipidation (including BK/KCa1.1) consolidate these themes [147,148].

Table 3. Lipid post-translational modifications (PTMs) effects on ion channels—Summary Table.

Lipid PTM	Ion Channel	Effect	References
S-palmitoylation	Nav1.5 (SCN5A)	↑ availability and late I_Na; action potential prolongation	[144]
	Kir6.2 (KATP)	↑ PIP2 sensitivity; ↑ current	[145]
	ENaC (γ subunit)	↑ open probability; ↑ activity	[149]
	TRPV1	promotes degradation	[142]
	BK (KCa1.1)	controls gating/trafficking	[150]
	BK (KCa1.1)	control of function and trafficking	[151]
	HCN4	↑ current density; altered activation kinetics	[146]
	Kv1.1	Regulates channel function/targeting	[152]
	CFTR (ABCC7)	Supports maturation and activity; inhibition reduces function	[153]
Myristoylation	BK (KCa1.1/Slo1)	alters current density and gating	[154]
	ENaC (via myristoylated MLP-1/MARCKS-like protein-1)	↑ ENaC activity via PIP2-dependent scaffolding	[155]
Prenylation	GIRK (Kir3.x)	required for GPCR→Gβγ activation of GIRK	[156]
GPI anchoring	Nav (RB sensory neurons, zebrafish)	required for Nav surface expression and firing	[157]
	Nav1.2/1.3/1.9	↑ Surface channel density via GPI-anchored adhesion molecule	[158]
	ENaC	Protease-dependent activation of ENaC; GPI-anchor regulates prostasin availability	[159]
	NMDAR	Modulates NMDA receptor activity/excitotoxicity	[160]

Table 3. Lipid post-translational modifications (PTMs) effects on ion channels—Summary Table.

Lipid PTM	Ion Channel	Effect	References
S-palmitoylation	Nav1.5 (SCN5A)	↑ availability and late I_Na; action potential prolongation	[144]
	Kir6.2 (KATP)	↑ PIP2 sensitivity; ↑ current	[145]
	ENaC (γ subunit)	↑ open probability; ↑ activity	[149]
	TRPV1	promotes degradation	[142]
	BK (KCa1.1)	controls gating/trafficking	[150]
	BK (KCa1.1)	control of function and trafficking	[151]
	HCN4	↑ current density; altered activation kinetics	[146]
	Kv1.1	Regulates channel function/targeting	[152]
	CFTR (ABCC7)	Supports maturation and activity; inhibition reduces function	[153]
Myristoylation	BK (KCa1.1/Slo1)	alters current density and gating	[154]
	ENaC (via myristoylated MLP-1/MARCKS-like protein-1)	↑ ENaC activity via PIP2-dependent scaffolding	[155]
Prenylation	GIRK (Kir3.x)	required for GPCR→Gβγ activation of GIRK	[156]
GPI anchoring	Nav (RB sensory neurons, zebrafish)	required for Nav surface expression and firing	[157]
	Nav1.2/1.3/1.9	↑ Surface channel density via GPI-anchored adhesion molecule	[158]
	ENaC	Protease-dependent activation of ENaC; GPI-anchor regulates prostasin availability	[159]
	NMDAR	Modulates NMDA receptor activity/excitotoxicity	[160]

In summary, lipid PTMs constitute essential molecular switches that dynamically couple membrane proteins—including ion channels—to the biophysical and organizational complexity of cellular membranes. Their reversibility (notably for S-acylation) and enzyme selectivity (zDHHC family; thioesterases) provide regulatory bandwidth and therapeutic entry points, while recent proteome-wide and chemical-genetic tools are accelerating substrate discovery and mechanism.

7. Lipid Rafts and Ion Channels

Lipid rafts are dynamic, cholesterol- and sphingolipid-enriched nanodomains of the plasma membrane that laterally organize signaling complexes and membrane proteins. Rather than being fixed “islands,” rafts are transient assemblies on the order of tens of nanometers that can coalesce into larger, stimulus-evoked platforms; their composition and size depend on local lipid balance (notably cholesterol and sphingolipids), cell type, and physiological state [161,162]. This mesoscale organization alters the local membrane order, thickness, and protein–lipid interactions, thereby tuning receptor coupling, second-messenger generation, and ion flux. In multiple tissues, raft remodeling is increasingly viewed as a therapeutic lever because it can reprogram membrane signaling with relative specificity [161]. A specialized form of lipid raft is the caveola, a flask-shaped (sub-100-nm) invagination stabilized by caveolin and cavin proteins and enriched in cholesterol. Caveolae act as mechanosensitive, signal-competent reservoirs that flatten under membrane tension and reform upon relaxation, thereby buffering stress while compartmentalizing receptors, channels, and enzymes [163,164]. Functionally, caveolae integrate mechanical and chemical cues—e.g., in endothelium, mechanosensitive caveolar domains modulate Ca²⁺ entry pathways to restrain inflammatory activation.

Ion channels frequently partition to rafts and caveolae, where their expression, biophysical gating, and coupling to signaling partners differ from non-raft regions. For Ca²⁺ entry, a subset of Orai1α/β subunits forms CRAC channels that reside in lipid rafts, linking raft composition to store-operated Ca²⁺ signaling [165]. TRP channels are likewise sensitive to raft lipid chemistry: sphingolipids are essential for proper TRPC5 localization and function, and disrupting sphingolipid balance mislocalizes the channel and alters Ca²⁺ signaling phenotypes [166]. For nociception, preserving raft integrity is required for the canonical behavior of TRP channels (e.g., TRPV1); pharmacologic raft disruption can dampen nociceptive signaling and produces analgesia in preclinical models [167,168]. Voltage-gated channels also exhibit raft-dependent behavior. In excitable sensory neurons, depleting cholesterol (a key raft component) triggers Nav1.9 dysfunction, illustrating how raft lipids set the operating range of a channel important for pain signaling [169]. Kv1.3 offers a well-studied caveolar example: direct interaction with caveolin governs Kv1.3 targeting to caveolae, where the channel engages distinct signaling ligands and scaffolds; caveolar targeting in adipocytes links Kv1.3 to insulin-dependent physiology, underscoring how domain context reshapes channel function [170]. Beyond cation channels, raft-associated P2X7 receptors upregulate caveolin-1 and foster macropore formation, coupling purinergic signaling to caveolar architecture [163]. More generally, ion channel function is measurably altered by nanoscale membrane order—changes in lipid nanodomain organization shift channel kinetics, voltage dependence, and pharmacology [162].

Multiple mechanisms “send” channels to rafts. First, specific protein–lipid interactions act as targeting signals: palmitoylation of channel subunits can promote raft partitioning, as shown for the voltage-gated sodium channel β2 subunit, which associates with lipid rafts via S-palmitoylation [171]. Second, protein–protein interactions recruit channels to caveolae; Kv1.3 contains caveolin-binding motifs whose engagement drives caveolar residency [172]. Third, the ambient lipid environment gates access: sphingolipid sufficiency is required for TRPC5 localization, and altering cholesterol content (with cyclodextrins or metabolic perturbations) displaces channels or changes their single-channel behavior [166,169].

Dysregulated channel expression or mislocalization in rafts is implicated in disease. Inflammation and immune function depend on raft-competent purinergic and T-cell signaling: P2X7–caveolin coupling promotes macropore formation in immune cells, while intact raft architecture is necessary for Jurkat T-cell migration [163,168]. In pain, targeted raft disruption reduces TRP-dependent nociception [167]. In infection and airway disease, second-hand smoke perturbs raft-dependent CFTR function and impairs macrophage phagocytosis [173]. In cancer, therapeutic alkyl ether lipids reorganize rafts, perturb death receptor and ion channel function, and thereby drive apoptosis and suppress migration [174]. Together, these examples support a unifying view: lipid rafts and caveolae are not passive anchors but active organizers whose lipid composition and scaffolding determine where ion channels live, how they gate, and with which signals they couple—properties that can be leveraged or derailed in physiology and disease [161,162].

8. Regulation of Ion Channels by the Physicochemical Properties of the Membrane Bilayer

Ion channels gate within—and in constant dialogue with—the lipid bilayer. Beyond specific lipid–protein binding, collective bilayer properties—surface charge, dipole potential, lateral pressure/stress, curvature elastic energy, lipid tail order, and bilayer thickness—reshape the energetic landscape for channel conformational change. Below, we outline how each property regulates distinct channel types, highlighting representative findings.

8.1. Surface Charge

Negative surface charge from anionic lipids (e.g., phosphatidylglycerol, phosphoinositides) and glycocalyx sialic acids can electrostatically shift voltage sensor energetics and pore stability. In Nav channels, enzymatic removal or differential addition of sialic acids causes marked, isoform-specific shifts in activation/inactivation (depolarizing the voltage dependence) in CHO and neuronal systems, consistent with an electrostatic surface-charge mechanism [175,176,177]. For Kir channels, highly charged anionic lipids—including PIP₂—are not just cofactors but can gate conduction; recent work shows anionic lipids act as “interactive response elements” that control Kir ion flux [178,179]. In Kv channels, anionic lipids can form state-dependent interactions with voltage-sensing arginines, stabilizing open states [50].

8.2. Dipole Potential

The membrane dipole potential—a steep electric field (~10⁸–10⁹ V m⁻¹) formed by oriented headgroups and interfacial water—modulates channel kinetics independent of transmembrane voltage. Classic gramicidin experiments with “dipole modifiers” (phloretin lowers, 6-ketocholestanol raises dipole potential) showed reciprocal changes in channel lifetimes and ion selectivity [180,181]. Reviews synthesize how altering dipole potential via amphiphiles or phytochemicals reshapes channel function in reconstituted systems and cells [182,183].

8.3. Lateral Pressure Profile & Membrane Tension (Lateral Stress)

Channel opening often changes a protein’s in-plane area and shape, coupling gating to the bilayer’s lateral-pressure profile. Amphiphilic drugs that soften or stiffen bilayers predictably shift channel energetics across families, as formalized by a ΔG_{bilayer} term [184]. The force-from-lipid principle—mechanical force transmitted through lipids—now spans prokaryotic and eukaryotic mechanosensors. K2P channels (TRAAK, TREK-1) are directly gated by bilayer tension, demonstrated in cells and purified systems [185,186]. Gramicidin channel dimerization and lifetime increase with applied tension, reporting the bilayer stress profile [187]. Comprehensive reviews trace the physical basis and channel exemplars of force-from-lipids [188,189].

8.4. Curvature Elastic Energy

Bilayers possess a bending modulus and spontaneous curvature; embedding or gating a protein imposes local curvature that costs elastic energy. Hydrophobic coupling between proteins and the hydrocarbon core means curvature/thickness deformations can functionally couple channels and bias states [190]. Continuum descriptions and single-molecule methods quantify how curvature and elastic constants set the “spring constants” for channel-induced deformations—illuminated using gramicidin as a reporter [191,192]. In sensory systems, mechanically tuned channels (e.g., PIEZO1/2) exemplify curvature/tension-dependent gating, though the dominant parameter appears to be a real tension in reconstituted bilayers. [193]

8.5. Lipid Tail Ordering and Membrane Fluidity

Bilayer order (acyl-chain packing) and fluidity influence channel dynamics and coupling to the bilayer field. For BK channels, lipids—including PUFAs and cholesterol—modify gating via direct interactions and bilayer remodeling [194,195]. In TRPV4, ω-3 PUFAs enhance function in endothelial cells, and EETs generated by PLA₂/cytochrome P450 couple cell swelling to activation—linking metabolic remodeling of order/packing to mechanochemical gating [196,197].

8.6. Bilayer Thickness (Hydrophobic Mismatch)

Changing hydrocarbon length alters hydrophobic mismatch with a channel’s transmembrane span, shifting gating equilibria. In gramicidin, chain-length-dependent bilayer thickness switches conformer preference and conductance states [198,199]. For the proton-gated bacterial KcsA channel, increasing acyl chain length (C18:1→C22:1) shifts pH-activation curves, and bilayer-modifying drugs map channel gating changes onto measured bilayer property changes—firm evidence for bilayer-mediated regulation [200].

Together, these studies argue that the bilayer acts as an active mechanical and electrostatic partner to channels: surface charge and dipole fields tune voltage sensors and permeation; lateral stress and curvature set mechanical work terms for gating; chain order and thickness act as knobs for hydrophobic coupling. Recognizing these collective bilayer effects explains why diverse amphiphiles, lipids, and mechanical cues can produce parallel shifts in gating across unrelated channel families.

9. Discussion

Over the past decade—and especially during the last five years—membrane lipids have moved from being viewed primarily as passive structural components to being recognized as information-rich modulators of ion channels. Consistent with the scope of this review, the diverse observations across channel families can be organized into four recurring (and often overlapping) mechanistic modes: (i) obligate lipid cofactors and electrostatic modulation, (ii) specific binding to annular or non-annular pockets, (iii) bilayer-mediated effects (thickness, curvature, lateral stress, surface charge, and dipole potential), and (iv) nanoscale membrane organization (rafts/caveolae) that governs clustering and trafficking [201,202,203].

First, the cofactor/electrostatic mode provides a unifying explanation for why receptor-driven lipid remodeling can rapidly reprogram excitability: anionic phosphoinositides such as PI(4,5)P2 stabilize activatable conformations and couple cytosolic gating elements to the pore in multiple channel families. When PI(4,5)P2 is depleted or redistributed, channels that depend on this permissive interaction can close or desensitize even in the absence of direct changes in voltage, ligand, or force, effectively converting enzymatic lipid signaling into electrical output. This principle is repeatedly supported by electrophysiology in native membranes and in controlled reconstitution systems (Table 1 and Table 2) [204].

Second, the pocket-binding mode is increasingly becoming residue-resolved and structure-led. Cryo-EM and crystallography now routinely capture lipid densities in functionally meaningful sites, while mutagenesis and simulations test whether occupancy stabilizes open, closed, or sensitized ensembles. Importantly, pocket-based mechanisms do not exclude bilayer physics: a lipid may act as a specific allosteric ligand while also contributing to local order and stress, and both contributions can be experimentally separable in simplified membranes versus intact cells [190,205].

Third, collective bilayer properties provide an energetically parsimonious framework for lipid effects that do not map to a single binding site. The lateral pressure profile, curvature elastic energy, and hydrophobic mismatch terms described in Section 8 predict that altering acyl-chain composition, cholesterol content, or amphiphile partitioning will bias conformational equilibria—an especially compelling explanation for mechanosensitive channels and K2P channels, where force-from-lipids and membrane mechanics are integral to gating. In this view, the bilayer is an allosteric partner whose material properties add a quantifiable contribution (ΔG_bilayer) to the gating landscape [190,205].

Fourth, nanoscale membrane organization connects lipid chemistry to cell biology. Rafts and caveolae can concentrate channels with receptors, scaffolds, and lipid-metabolic enzymes, thereby tuning local lipid availability and reaction kinetics. Live-cell fluorescence approaches that are compatible with single-molecule sensitivity (e.g., FCS and fluctuation-based methods) help resolve these effects by quantifying mobility, confinement, and partitioning that are not accessible from ensemble electrophysiology alone [206]. For example, cholesterol depletion alters Orai1 localization and shifts its lateral dynamics toward less obstructed diffusion, effects buffered by caveolin-1 and consistent with cholesterol-rich domains controlling compartmentalization and trafficking [207]. Single-particle tracking further supports a diffusion–trap model of STIM1–Orai1 assembly at ER–PM junctions, in which trapping and escape of individual complexes are dynamically regulated by binding affinities and expression ratios [208,209].

Related strategies applied to other channels reinforce the same logic. Spatio-temporal fluctuation analysis together with FRET imaging resolved TRPV1 into membrane populations with distinct mobility and interaction partners, including a caveolin-associated fraction confined to caveolar structures—supporting the concept that cholesterol-enriched nanodomains can regulate signaling and desensitization by controlling spatial organization and endocytic routing [210]. More broadly, these live-cell measurements bridge the “lipid pocket” and “membrane domain” paradigms by revealing when lipid modulation is mediated by altered residence time, confinement, and clustering rather than by occupancy of a single site [211]. At the reconstitution level, single-molecule fluorescence can also report lipid-driven conformational dynamics directly; for example, smFRET on liposome-reconstituted MscL quantified helix movements during gating and constrained the size of the fully open pore, complementing ensemble electrophysiology and highlighting how lipid environments tune mechanosensitive transitions [209]. Recent mechanosensitive channel work further shows how lipid occupancy of hydrophobic pockets can tune tension thresholds and produce pronounced gating hysteresis, emphasizing that even within one channel family, lipids may act as critical gating elements or more purely structural stabilizers depending on architecture and pocket geometry [212].

Despite rapid progress, most channel types still lack quantitative, state-resolved maps of their lipid interactomes in native membranes. A central near-term goal is to integrate structural snapshots with single-channel kinetics and live-cell measurements of nanoscale organization in matched systems, allowing lipid composition, domain partitioning, and gating energetics to be coupled directly rather than inferred separately [213,214]. Achieving this integration should accelerate both mechanism-based therapeutic strategies—targeting defined lipid pockets, retuning bilayer mechanics or nanodomain composition, or modulating lipid enzymes that set local messenger pools—and the interpretation of channelopathies rooted in disrupted lipid milieus [213,214].

10. Conclusions

Membrane lipids should be regarded as co-regulators of ion channels, not passive solvents. Across families, two complementary mechanisms recur—specific lipid binding at non-annular pockets and bilayer-level control through surface charge, thickness, curvature, and lateral pressure—each capable of shifting gating equilibria, kinetics, and membrane abundance. Recent work crystallizes this view: cryo-EM, often in nanodiscs/vesicles, now resolves endogenous phospholipids and sterols in situ and, together with mutagenesis and atomistic MD, maps allosteric pathways from lipid pockets to gates; complementary native mass spectrometry and lipidomics (down to single-cell/subcellular scales) quantify retained lipids and preferences, directly linking lipid binding to function.

Mechanistically, several exemplars anchor general principles. Neutral lipids such as DAG act as direct ligands for canonical TRPCs via lateral fenestrations that sensitize opening, while neighboring phosphoinositide sites cooperate during PLC signaling. Sterols illustrate dual routes—pocket binding and membrane organization—with endogenous cholesterol captured in the TRPV2 vanilloid pocket antagonizing gating, and with Kir2 suppression providing a counterpoint to PI-driven activation. K2P leak channels (e.g., TREK1) exemplify convergence of headgroup chemistry and packing on filter and helix gates, while PLD-generated PA/LPA selectively inhibit PIEZO2 in cells and in vivo, underscoring lipid–channel specificity. Finally, rafts/caveolae provide mesoscale scaffolds that cluster channels with partners, re-tune kinetics and voltage dependence, and gate access to lipid cofactors.

Translationally, decoding lipid–channel crosstalk opens drugging strategies that (i) target defined lipid pockets, (ii) retune bilayer mechanics or nanodomain composition, and (iii) modulate lipid enzymes/pathways that set local messenger pools—approaches already being explored in pain, vascular, and epithelial disease contexts. Yet, key gaps remain. For most channels we still lack state-resolved, quantitative maps of lipid occupancy and selectivity in native membranes; we know little about real-time integration of multiple lipid cues under physiological signaling; and the rules of combinatorial lipid coding across cell types and organelles are only beginning to emerge. Addressing these challenges will require time-resolved structural methods, in situ biophysics, native MS, and single-cell/organelle lipidomics integrated with advanced electrophysiology to move from static snapshots to predictive mechanisms.

In recent years, the field has undergone a step-change in mechanistic clarity and methodological power, but a general, channel-by-channel rulebook for lipid modulation is still ahead. Closing this gap should accelerate therapeutic design for channelopathies rooted in disrupted lipid milieus.